Immunomodulatory fusion protein-metal hydroxide complexes and methods thereof
US11642409B2 · kind B2 · utility
0Cited by
1References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 24, 2020 |
| Grant date | May 9, 2023 |
| Priority date | — |
| Expiry date | Dec 24, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N9/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides immunomodulatory fusion proteins-metal hydroxide complexes comprising an immunomodulatory domain adsorbed to a metal hydroxide via ligand exchange. The disclosure also features compositions and methods of using the same, for example, to treat cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.